BMS Is Latest To Join Synthetic Lethality Bandwagon With Volastra Deal

 
• By Alaric DeArment
Cancer - DNA - test tube
BMS signed a deal with Volastra focused on synthetic lethality in oncology • Source: Shutterstock

More from Anticancer

More from Therapeutic Category